Citations for
1APOBEC3F, APOBEC3G
Inhibition of APOBEC3G activity impedes double-stranded DNA repair.
Prabhu P, Shandilya SM, Britan-Rosich E, Nagler A, Schiffer CA, Kotler M.
FEBS J 283(1):112-29. doi: 10.1111/febs.13556. Epub 2015 Nov 6. 2016
2APOBEC3A, APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G, APOBEC3H
APOBEC3A damages the cellular genome during DNA replication.
Green AM, Landry S, Budagyan K, Avgousti DC, Shalhout S, Bhagwat AS, Weitzman MD.
Cell Cycle 15(7):998-1008. doi: 10.1080/15384101.2016.1152426. 2016
3APOBEC3F
Structural Insights into HIV-1 Vif-APOBEC3F Interaction.
Nakashima M, Ode H, Kawamura T, Kitamura S, Naganawa Y, Awazu H, Tsuzuki S, Matsuoka K, Nemoto M, Hachiya A, Sugiura W, Yokomaku Y, Watanabe N, Iwatani Y.
J Virol 90(2):1034-47. doi: 10.1128/JVI.02369-15. 2015
4APOBEC3F, APOBEC3G
Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3G.
Bélanger K, Langlois MA.
J Gen Virol 96(9):2878-87. doi: 10.1099/vir.0.000214. Epub 2015 Jun 5. 2015
5APOBEC3F
Genetic analysis of the localization of APOBEC3F to human immunodeficiency virus type 1 virion cores.
Donahue JP, Levinson RT, Sheehan JH, Sutton L, Taylor HE, Meiler J, D'Aquila RT, Song C.
J Virol 89(4):2415-24. doi: 10.1128/JVI.01981-14. Epub 2014 Dec 10. 2015
6APOBEC3F
APOBEC3F determinants of HIV-1 Vif sensitivity.
Land AM, Shaban NM, Evans L, Hultquist JF, Albin JS, Harris RS.
J Virol 88(21):12923-7. doi: 10.1128/JVI.02362-14. Epub 2014 Aug 20. 2014
7APOBEC3F, APOBEC3G
Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles.
Wang X, Li X, Ma J, Zhang L, Ma L, Mi Z, Zhou J, Guo F, Kleiman L, Cen S.
Virus Res 191:30-8. doi: 10.1016/j.virusres.2014.07.011. Epub 2014 Jul 16. 2014
8APOBEC3F
Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.
Albin JS, Brown WL, Harris RS.
Virology 450-451:49-54. doi: 10.1016/j.virol.2013.11.041. Epub 2013 Dec 20. 2014
9APOBEC3F, APOBEC3G
Nuclear import of APOBEC3F-labeled HIV-1 preintegration complexes.
Burdick RC, Hu WS, Pathak VK.
Proc Natl Acad Sci U S A 110(49):E4780-9. doi: 10.1073/pnas.1315996110. Epub 2013 Nov 18. 2013
10APOBEC3F, APOBEC3G
Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.
Song C, Sutton L, Johnson ME, D'Aquila RT, Donahue JP.
J Biol Chem 287(20):16965-74. doi: 10.1074/jbc.M111.310839. Epub 2012 Mar 28. 2012
11APOBEC3F, APOBEC3G, APOBEC3H
The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
Binka M, Ooms M, Steward M, Simon V.
J Virol 86(1):49-59. doi: 10.1128/JVI.06082-11. Epub 2011 Oct 19. 2012
12APOBEC3F, APOBEC3G
Structural Features of Antiviral APOBEC3 Proteins are Linked to Their Functional Activities.
Kitamura S, Ode H, Iwatani Y.
Front Microbiol 2:258. doi: 10.3389/fmicb.2011.00258. eCollection 2011. 2011
13APOBEC3F, APOBEC3G
Identification of two APOBEC3F splice variants displaying HIV-1 antiviral activity and contrasting sensitivity to Vif.
Lassen KG, Wissing S, Lobritz MA, Santiago M, Greene WC.
J Biol Chem 285(38):29326-35. Epub 2010 Jul 12. 2010
14APOBEC3F, APOBEC3G
Stably expressed APOBEC3F has negligible antiviral activity.
Miyagi E, Brown CR, Opi S, Khan M, Goila-Gaur R, Kao S, Walker RC Jr, Hirsch V, Strebel K.
J Virol 84(21):11067-75. Epub 2010 Aug 11. 2010
15APOBEC3F
Moderate influence of human APOBEC3F on HIV-1 replication in primary lymphocytes.
Mulder LC, Ooms M, Majdak S, Smedresman J, Linscheid C, Harari A, Kunz A, Simon V.
J Virol 84(18):9613-7. Epub 2010 Jun 30. 2010
16APOBEC3F, APOBEC3G
APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.
Mbisa JL, Bu W, Pathak VK.
J Virol 84(10):5250-9. Epub 2010 Mar 10. 2010
17APOBEC3F, APOBEC3H
A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif.
Albin JS, LaRue RS, Weaver JA, Brown WL, Shindo K, Harjes E, Matsuo H, Harris RS.
J Biol Chem 285(52):40785-92. Epub 2010 Oct 22. 2010
18APOBEC3F, APOBEC3G
Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.
Henriet S, Mercenne G, Bernacchi S, Paillart JC, Marquet R.
Microbiol Mol Biol Rev 73(2):211-32. Review. 2009
19APOBEC3F, APOBEC3G
Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.
Russell RA, Smith J, Barr R, Bhattacharyya D, Pathak VK.
J Virol 83(4):1992-2003. Epub 2008 Nov 26. 2009
20APOBEC3F, APOBEC3G
Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins.
Gallois-Montbrun S, Holmes RK, Swanson CM, Fernández-Ocaña M, Byers HL, Ward MA, Malim MH.
J Virol 82(11):5636-42. Epub 2008 Mar 26. 2008
21APOBEC3G, APOBEC3F
Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.
Russell RA, Pathak VK.
J Virol 81(15):8201-10. Epub 2007 May 23. 2007
22APOBEC3G, APOBEC3F
APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.
Pion M, Granelli-Piperno A, Mangeat B, Stalder R, Correa R, Steinman RM, Piguet V.
J Exp Med 203(13):2887-93. Epub 2006 Dec 4. 2006
23APOBEC3F, APOBEC3G
Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains.
Hakata Y, Landau NR.
J Biol Chem 281(48):36624-31. Epub 2006 Oct 4. 2006
24APOBEC3F, APOBEC3G
The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain.
Hache G, Liddament MT, Harris RS.
J Biol Chem 280(12):10920-4. Epub 2005 Jan 12. 2005
25APOBEC3A, APOBEC3B, APOBEC1, APOBEC3A, APOBEC3B, APOBEC3C, APOBEC3D, APOBEC3F, APOBEC3G
An Anthropoid-Specific Locus of Orphan C to U RNA-Editing Enzymes on Chromosome 22.
Jarmuz A, Chester A, Bayliss J, Gisbourne J, Dunham I, Scott J, Navaratnam N.
Genomics 79(3):285-96. 2002